Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angongniuhuang Pill for Restoring Consciousness in Acute Ischemic Stroke
NCT00817609Phase 3Unknown
- Sponsor
- Fudan University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in ischemic stroke comparing Angongniuhuang Pill with Placebo (2 arms). Primary endpoint: Glasgow Coma Scale at 90 days. Status: unknown.
02
Drugs
An'gong Niuhuang Pill
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00817609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817609.